3Enting RH,Oldenmenger WH,van der Rijt CC,et al.A prospective study evaluating the response of patients with unrelieved cancer pain to parenteral opioids.Cancer,2002,94(11):3049-3056.
4Wilson Tay,Kok-Yuen Ho.The Role of Interventional Therapies in Cancer Pain Management.Ann Acad Med Singapore,2009,38(11):989-997.
5Burton AW,Rajagopal A,Shah HN,et al.Epidural and intrathecal analgesia is effective in treating refractory cancer pain.Pain Med,2004,5(3):239.
6Exner HJ,Peters J,Eikermann M.Epidural analgesia at end of life:facing empirical contraindications.Anesth Analg,2003,97(6):1740.
7Krames ES,Lanning RM.Intrathecal infusional analgesia for nonmalignant pain:analgesic efficacy of intrathecal opioid with or without bupivacaine.Pain Symptom Manage,1993,8(8):539-548.
8Crosby E,Sandler A,Finucane B,et al.Comparison of epidural anaesthesia with ropivacaine 0.5% and bupivacaine 0.5% for caesarean section[J] .Can J Anaesth,1998,45(11):1066-1071.
9Itzgibbon EJ,Viola R.Parenteral ketamine as an analgesic adjuvant for severe pain:development and retrospective audit of a protocol for a palliative care unit.Palliat Med,2005,8(1):49-57.
10Ghai B,Makkar JK,Chari P,et al.Addition of midazolam to continuous postoperative epidural bupivacaine infusion reduces requirement for rescue analgesia in children undergoing upper abdominal and flank surgery.Clin Anesth,2009,21(2):113-119.
